IDEXX Laboratories, Inc.IDXXNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank28
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P28
Within normal range
vs 5Y Ago
-1.4x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -11.06% |
| Q3 2025 | -4.88% |
| Q2 2025 | 17.85% |
| Q1 2025 | 20.96% |
| Q4 2024 | -13.89% |
| Q3 2024 | 15.20% |
| Q2 2024 | -11.76% |
| Q1 2024 | 21.87% |
| Q4 2023 | -10.89% |
| Q3 2023 | -7.04% |
| Q2 2023 | 5.62% |
| Q1 2023 | 23.78% |
| Q4 2022 | -7.48% |
| Q3 2022 | 36.73% |
| Q2 2022 | -27.90% |
| Q1 2022 | 24.68% |
| Q4 2021 | -11.85% |
| Q3 2021 | -12.84% |
| Q2 2021 | 4.70% |
| Q1 2021 | 33.78% |
| Q4 2020 | 7.70% |
| Q3 2020 | -11.07% |
| Q2 2020 | 33.90% |
| Q1 2020 | 24.82% |
| Q4 2019 | -17.29% |
| Q3 2019 | -14.90% |
| Q2 2019 | 23.39% |
| Q1 2019 | 15.42% |
| Q4 2018 | -1.71% |
| Q3 2018 | -19.40% |
| Q2 2018 | 28.79% |
| Q1 2018 | 15.58% |
| Q4 2017 | -2.59% |
| Q3 2017 | -18.07% |
| Q2 2017 | 32.87% |
| Q1 2017 | 10.04% |
| Q4 2016 | -5.24% |
| Q3 2016 | -15.08% |
| Q2 2016 | 41.15% |
| Q1 2016 | 10.29% |